KR100820609B1 - 고형 제제 - Google Patents
고형 제제 Download PDFInfo
- Publication number
- KR100820609B1 KR100820609B1 KR1020057006007A KR20057006007A KR100820609B1 KR 100820609 B1 KR100820609 B1 KR 100820609B1 KR 1020057006007 A KR1020057006007 A KR 1020057006007A KR 20057006007 A KR20057006007 A KR 20057006007A KR 100820609 B1 KR100820609 B1 KR 100820609B1
- Authority
- KR
- South Korea
- Prior art keywords
- solid preparation
- median size
- insulin sensitizer
- active ingredient
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Abstract
Description
염산 피오글리타존 | 염산 메트포르민 | |
실시예 1 | 3.5 | 0.8 |
실시예 2 | 0.5 | 0.3 |
실시예 3 | 1.1 | 0.7 |
실시예 5 | 1.0 | 0.5 |
실시예 6 | 0.6 | 0.5 |
비교예 1 | 7.6 | 1.2 |
정제 경도 (N) | |
실시예 1 | 181 |
실시예 2 | 210 |
실시예 3 | 250 |
실시예 5 | 223 |
실시예 6 | 289 |
비교예 1 | 80 |
시간 | 15분 | 30분 | 45분 | 60분 |
실시예 2 | 85.6 | 95.8 | 98.5 | 99.5 |
실시예 3 | 83.1 | 94.1 | 97.7 | 98.6 |
실시예 5 | 93.0 | 100.7 | - | - |
실시예 6 | 89.0 | 100.0 | - | - |
Claims (15)
- 삭제
- 삭제
- 삭제
- 피오글리타존 또는 그의 염과 비구아니드가 균일하게 분산된 상을 갖고, 상기 피오글리타존 또는 그의 염의 중위 (median) 크기에 대한 상기 비구아니드의 중위 크기의 비가 0.5 내지 15 이고, 피오글리타존 또는 그의 염의 중위 크기는 1 내지 25 ㎛이며, 비구아니드의 중위 크기는 10 내지 100 ㎛인 고형 제제.
- 삭제
- 제 4 항에 있어서, 상기 비구아니드가 염산 메트포르민인 고형 제제.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 제 4 항에 있어서, 염산 피오글리타존과 염산 메트포르민이 균일하게 분산된 상을 갖고, 상기 염산 피오글리타존의 중위 크기에 대한 상기 염산 메트포르민의 중위 크기의 비가 0.5 내지 15 인 고형 제제.
- 제 13 항에 있어서, 필름 코팅되어 있는 고형 제제.
- 제 4 항에 있어서, 피오글리타존 또는 그의 염이 염산 피오글리타존인 고형 제제.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002294045 | 2002-10-07 | ||
JPJP-P-2002-00294045 | 2002-10-07 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020077027585A Division KR20070119095A (ko) | 2002-10-07 | 2003-10-06 | 고형 제제 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050070039A KR20050070039A (ko) | 2005-07-05 |
KR100820609B1 true KR100820609B1 (ko) | 2008-04-10 |
Family
ID=32064024
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020057006007A KR100820609B1 (ko) | 2002-10-07 | 2003-10-06 | 고형 제제 |
KR1020077027585A KR20070119095A (ko) | 2002-10-07 | 2003-10-06 | 고형 제제 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020077027585A KR20070119095A (ko) | 2002-10-07 | 2003-10-06 | 고형 제제 |
Country Status (26)
Country | Link |
---|---|
US (1) | US9101660B2 (ko) |
EP (1) | EP1561472B2 (ko) |
JP (2) | JP4236553B2 (ko) |
KR (2) | KR100820609B1 (ko) |
CN (1) | CN100427143C (ko) |
AU (1) | AU2003271103B2 (ko) |
BR (1) | BR0315082A (ko) |
CA (1) | CA2501587C (ko) |
CO (1) | CO5700740A2 (ko) |
CR (1) | CR7797A (ko) |
CY (1) | CY1114863T1 (ko) |
DK (1) | DK1561472T3 (ko) |
ES (1) | ES2437072T5 (ko) |
HK (1) | HK1080385A1 (ko) |
IL (1) | IL167835A (ko) |
MA (1) | MA27487A1 (ko) |
MX (1) | MXPA05003668A (ko) |
NO (1) | NO332993B1 (ko) |
NZ (2) | NZ539711A (ko) |
PL (1) | PL219608B1 (ko) |
PT (1) | PT1561472E (ko) |
RU (1) | RU2357757C2 (ko) |
SI (1) | SI1561472T1 (ko) |
UA (1) | UA80991C2 (ko) |
WO (1) | WO2004030700A1 (ko) |
ZA (1) | ZA200503507B (ko) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101114808B1 (ko) | 2003-01-29 | 2012-02-15 | 다케다 야쿠힌 고교 가부시키가이샤 | 피복 제제의 제조법 |
US7198653B2 (en) | 2003-07-31 | 2007-04-03 | Delavau Llc | Calcium carbonate granulation |
NZ546337A (en) | 2003-10-31 | 2009-03-31 | Takeda Pharmaceutical | Solid preparation comprising an insulin sensitizer such as pioglitazone hydrochloride, an insulin secretagogue such as glimepiride and a polyoxyethylene sorbitan fatty acid ester such as Polysorbate 80 |
US8263121B2 (en) | 2004-04-14 | 2012-09-11 | Takeda Pharmaceutical Company Limited | Solid pharmaceutical preparation |
KR20080007371A (ko) * | 2005-04-26 | 2008-01-18 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 비구아니드 화합물 함유 과립성 제제 |
ZA200805147B (en) | 2005-12-22 | 2010-05-26 | Takeda Pharmaceutical | Solid preparation |
KR101220643B1 (ko) * | 2006-08-16 | 2013-01-14 | 알리코제약(주) | 사포그릴레이트 함유 경구투여 형태의 약제 |
US9138414B1 (en) | 2006-09-15 | 2015-09-22 | Delavau Llc | Calcium supplement having enhanced absorption |
JP4832271B2 (ja) * | 2006-12-11 | 2011-12-07 | 花王株式会社 | 粉末圧縮錠剤 |
MY159203A (en) | 2007-07-19 | 2016-12-30 | Takeda Pharmaceuticals Co | Solid preparation comprising alogliptin and metformin hydrochloride |
US8563500B2 (en) | 2007-09-05 | 2013-10-22 | Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | Methods and compounds for treating diseases caused by reactive oxygen species |
CN101417130B (zh) * | 2007-10-22 | 2010-10-06 | 鲁南制药集团股份有限公司 | 一种治疗ⅱ型糖尿病及其并发症的药物组合物 |
TR200803177A2 (tr) * | 2008-05-06 | 2009-11-23 | Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. | Antihiperglisemik etkili metformîn - pioglitazon formülasyonu. |
WO2010084504A2 (en) * | 2008-05-26 | 2010-07-29 | Sun Pharmaceutical Industries Ltd. | A stable, oral solid dosage form |
US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
TW201138843A (en) | 2009-12-18 | 2011-11-16 | Colgate Palmolive Co | Biguanide preservation of precipitated calcium carbonate |
CA2785487C (en) | 2009-12-23 | 2017-11-28 | Ratiopharm Gmbh | Solid pharmaceutical dosage form of ticagrelor |
WO2012012156A1 (en) * | 2010-07-21 | 2012-01-26 | Myomics, Inc. | Methods and compositions for the improvement of skeletal muscle function in a mammal |
EP2441442A1 (en) | 2010-10-08 | 2012-04-18 | LEK Pharmaceuticals d.d. | A pharmaceutical composition comprising a thiazolidinedione |
TWI631963B (zh) * | 2011-01-05 | 2018-08-11 | 雷西肯製藥股份有限公司 | 包含鈉-葡萄糖共同輸送體1與2之抑制劑的組合物與應用方法 |
RU2465896C2 (ru) * | 2011-01-20 | 2012-11-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая противодиабетическая композиция пролонгированного действия |
CN105125539A (zh) * | 2015-08-05 | 2015-12-09 | 浙江华海药业股份有限公司 | 吡格列酮二甲双胍片及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001035941A2 (en) * | 1999-11-16 | 2001-05-25 | Smithkline Beecham P.L.C. | Novel composition based on a thiazolidinedione and metformin and use |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE216577T1 (de) * | 1992-01-29 | 2002-05-15 | Takeda Chemical Industries Ltd | Schnellösliche tablette und ihre herstellung |
TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
AU713462B2 (en) * | 1996-07-12 | 1999-12-02 | Daiichi Pharmaceutical Co., Ltd. | Quickly disintegrable compression-molded materials and process for producing the same |
US6291495B1 (en) * | 1997-02-24 | 2001-09-18 | Robert B. Rieveley | Method and composition for the treatment of diabetes |
US6153632A (en) * | 1997-02-24 | 2000-11-28 | Rieveley; Robert B. | Method and composition for the treatment of diabetes |
US20020004515A1 (en) * | 1997-06-18 | 2002-01-10 | Smith Stephen Alistair | Treatment of diabetes with thiazolidinedione and metformin |
ES2284212T3 (es) * | 1997-06-18 | 2007-11-01 | Smithkline Beecham Plc | Tratamiento de diabetes con tiazolidinadiona y metformina. |
GB9715295D0 (en) | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
JPH1160476A (ja) * | 1997-08-25 | 1999-03-02 | Taisho Pharmaceut Co Ltd | 圧縮固形組成物 |
EA003101B1 (ru) | 1998-03-19 | 2002-12-26 | Бристол-Майерз Сквибб Компани | Двухфазная система доставки с регулируемым высвобождением для фармацевтических средств с высокой растворимостью и способ лечения диабета с помощью этой системы |
ES2237121T3 (es) * | 1998-07-28 | 2005-07-16 | Takeda Pharmaceutical Company Limited | Preparacion solida disgregable rapidamente. |
US6117451A (en) * | 1998-08-25 | 2000-09-12 | Pharmalogix, Inc. | Direct compression metformin hydrochloride tablets |
CZ20011629A3 (cs) | 1998-11-12 | 2001-12-12 | Smithkline Beecham Plc | Farmaceutický prostředek pro upravené uvolňování senzitizéru inzulínu a jiných antidiabetických přípravků |
KR100689943B1 (ko) | 1998-12-24 | 2007-03-08 | 메타베이시스 테라퓨틱스, 인크. | 당뇨병 치료용 FBPase 억제제 및 인슐린 증감제의조합물 |
CA2371391A1 (en) | 1999-04-29 | 2000-11-09 | City Of Hope | Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's) |
AR028299A1 (es) | 1999-09-17 | 2003-05-07 | Novartis Ag | Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes. |
US6586438B2 (en) | 1999-11-03 | 2003-07-01 | Bristol-Myers Squibb Co. | Antidiabetic formulation and method |
AU1403501A (en) | 1999-11-16 | 2001-05-30 | Smithkline Beecham Plc | Novel composition and use |
US6403121B1 (en) * | 2000-05-01 | 2002-06-11 | Aeropharm Technology Incorporated | Core formulation |
US6780432B1 (en) | 2000-05-01 | 2004-08-24 | Aeropharm Technology, Inc. | Core formulation |
US6524621B2 (en) * | 2000-05-01 | 2003-02-25 | Aeropharm Technology Inc. | Core formulation |
JP2001335469A (ja) * | 2000-05-26 | 2001-12-04 | Lion Corp | 固体製剤の製造方法 |
FR2812547B1 (fr) * | 2000-08-04 | 2002-10-31 | Lipha | Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete |
JP2002087965A (ja) | 2000-09-14 | 2002-03-27 | Lion Corp | 口中崩壊性アスピリン含有錠剤 |
JP4284017B2 (ja) * | 2000-10-06 | 2009-06-24 | 武田薬品工業株式会社 | 固形製剤 |
AU2001294192A1 (en) * | 2000-10-06 | 2002-04-22 | Takeda Chemical Industries Ltd. | Solid preparations |
UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
CN100367960C (zh) | 2002-07-11 | 2008-02-13 | 武田药品工业株式会社 | 包衣制剂的制备方法 |
-
2003
- 2003-06-10 UA UAA200504320A patent/UA80991C2/uk unknown
- 2003-10-06 CA CA002501587A patent/CA2501587C/en not_active Expired - Lifetime
- 2003-10-06 DK DK03751344.7T patent/DK1561472T3/da active
- 2003-10-06 PT PT37513447T patent/PT1561472E/pt unknown
- 2003-10-06 BR BR0315082-8A patent/BR0315082A/pt not_active Application Discontinuation
- 2003-10-06 AU AU2003271103A patent/AU2003271103B2/en not_active Expired
- 2003-10-06 CN CNB2003801044191A patent/CN100427143C/zh not_active Expired - Lifetime
- 2003-10-06 WO PCT/JP2003/012781 patent/WO2004030700A1/ja not_active Application Discontinuation
- 2003-10-06 KR KR1020057006007A patent/KR100820609B1/ko active IP Right Grant
- 2003-10-06 PL PL376176A patent/PL219608B1/pl unknown
- 2003-10-06 RU RU2005113999/15A patent/RU2357757C2/ru active
- 2003-10-06 NZ NZ539711A patent/NZ539711A/en not_active IP Right Cessation
- 2003-10-06 US US10/530,262 patent/US9101660B2/en active Active
- 2003-10-06 NZ NZ552559A patent/NZ552559A/en not_active IP Right Cessation
- 2003-10-06 MX MXPA05003668A patent/MXPA05003668A/es active IP Right Grant
- 2003-10-06 JP JP2003346699A patent/JP4236553B2/ja not_active Expired - Lifetime
- 2003-10-06 EP EP03751344.7A patent/EP1561472B2/en not_active Expired - Lifetime
- 2003-10-06 ES ES03751344T patent/ES2437072T5/es not_active Expired - Lifetime
- 2003-10-06 SI SI200332322T patent/SI1561472T1/sl unknown
- 2003-10-06 KR KR1020077027585A patent/KR20070119095A/ko not_active Application Discontinuation
-
2005
- 2005-04-03 IL IL167835A patent/IL167835A/en unknown
- 2005-04-19 CR CR7797A patent/CR7797A/es unknown
- 2005-05-03 ZA ZA200503507A patent/ZA200503507B/en unknown
- 2005-05-04 MA MA28258A patent/MA27487A1/fr unknown
- 2005-05-05 CO CO05043503A patent/CO5700740A2/es not_active Application Discontinuation
- 2005-05-06 NO NO20052239A patent/NO332993B1/no not_active IP Right Cessation
-
2006
- 2006-01-12 HK HK06100508.9A patent/HK1080385A1/xx not_active IP Right Cessation
-
2008
- 2008-05-12 JP JP2008125325A patent/JP2008208141A/ja active Pending
-
2013
- 2013-12-09 CY CY20131101109T patent/CY1114863T1/el unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001035941A2 (en) * | 1999-11-16 | 2001-05-25 | Smithkline Beecham P.L.C. | Novel composition based on a thiazolidinedione and metformin and use |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100820609B1 (ko) | 고형 제제 | |
KR101114808B1 (ko) | 피복 제제의 제조법 | |
JP4739189B2 (ja) | 固形製剤 | |
JP5179363B2 (ja) | 固形製剤 | |
RU2359671C2 (ru) | Способ получения препарата с покрытием | |
KR20060016787A (ko) | 고형 약학 제제 | |
IL174201A (en) | Solid preparation comprising a pioglitazone layer and a layer comprisinig glimepiride and polysorbate 80 | |
JP4567340B2 (ja) | 被覆製剤の製造方法 | |
JP4361461B2 (ja) | 固形製剤 | |
CN1761465B (zh) | 制备被覆制剂的方法 | |
JP4478413B2 (ja) | 被覆製剤の製造法 | |
JP2005015477A (ja) | 固形製剤 | |
KR20050017090A (ko) | 코팅제의 제조 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
A107 | Divisional application of patent | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130321 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140319 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20160318 Year of fee payment: 9 |
|
J206 | Request for trial to confirm the scope of a patent right | ||
J206 | Request for trial to confirm the scope of a patent right | ||
FPAY | Annual fee payment |
Payment date: 20170302 Year of fee payment: 10 |
|
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2016100004146; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161223 Effective date: 20170424 Free format text: TRIAL NUMBER: 2016100004151; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161223 Effective date: 20170424 Free format text: TRIAL NUMBER: 2016100004150; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161223 Effective date: 20170424 Free format text: TRIAL NUMBER: 2016100004147; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161223 Effective date: 20170424 Free format text: TRIAL NUMBER: 2016100004149; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161223 Effective date: 20170424 Free format text: TRIAL NUMBER: 2016100003973; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161209 Effective date: 20170424 Free format text: TRIAL NUMBER: 2016100004148; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161223 Effective date: 20170424 |